Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01505569
Title Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Masonic Cancer Center, University of Minnesota
Indications

Advanced Solid Tumor

Therapies

Filgrastim

Busulfan + Melphalan

Etoposide + Ifosfamide

Thiotepa

Carboplatin

Age Groups: senior | child | adult
Covered Countries USA


No variant requirements are available.